A recent report also has shown that ARB efficiently attenuated AT-II-induced HCC cell proliferation by inhibiting the AT1R/Raf/extracellular signal-regulated kinase (ERK)1/2 signaling pathway [20]. Here, MAPK3 is linked to hepatocellular carcinoma.